Abeona Therapeutics (ABEO) Notes Payables (2014)
Abeona Therapeutics' (ABEO) quarterly Notes Payables came in at $400000.0 in Q4 2014, up 60.0% quarter-over-quarter from $250000.0 in Q3 2014.
Abeona Therapeutics (ABEO) Notes Payables (2014) Analysis & Trends
Abeona Therapeutics' Notes Payables history runs 1 years deep, the most recent figure standing at $400000.0 for Q4 2014.
- On a quarterly basis, Notes Payables changed N/A year-over-year to $400000.0 in Q4 2014; TTM through Dec 2014 was $400000.0, a N/A change from a year earlier, with the FY2014 full-year figure at $400000.0, changed N/A from the prior year.
- Notes Payables grew to $400000.0 in Q4 2014 per ABEO's latest filing, from $250000.0 in the prior quarter.
- Across five years, Notes Payables topped out at $400000.0 in Q4 2014 and bottomed at $250000.0 in Q3 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Abeona Therapeutics | 107.85 Mn | -60.42 Mn | 6.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 400,000.00 |
| Sep 30, 2014 | 250,000.00 |